Xue-Yun Zhong
Overview
Explore the profile of Xue-Yun Zhong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li N, Nan C, Zhong X, Weng J, Fan H, Sun H, et al.
Cell Physiol Biochem
. 2018 Sep;
49(4):1329-1341.
PMID: 30205384
Background/aims: Emerging evidence suggests that the propagation of oral squamous cell carcinoma (OSCC) is influenced by the abnormal expression of microRNAs (miRNAs). This study aimed to characterize the involvement of...
2.
Ma J, Wang X, Chang L, Zhong X, Jing H, Zhu X, et al.
Exp Cell Res
. 2018 Jun;
370(1):58-67.
PMID: 29894706
CD44, a glycoprotein, has been reported to have relationship with resistance to radiation in prostate cancer (Cap) cells. However, its molecular mechanism remains unknown. In this study, we demonstrated that...
3.
Zhang Y, Wen Y, Ma J, Ye J, Wang X, Huang J, et al.
Int J Oncol
. 2016 Dec;
50(1):101-110.
PMID: 27909720
Cancer stem cells (CSCs) in glioma are often responsible for relapse and resistance to therapy. The purpose of the present study was to confirm the self-renewal and migration inhibitory effects...
4.
Ma J, Zhang Y, Ye J, Li R, Wen Y, Huang J, et al.
Biomol Ther (Seoul)
. 2016 Nov;
25(2):186-193.
PMID: 27829269
Tetrandrine (Tet), a bisbenzylisoquinoline alkaloid, has been reported to have a radiosensitization effect on tumors. However, its effects on human glioma and the specific molecular mechanisms of these effects remain...
5.
Ma J, Zhang Y, Li R, Ye J, Li H, Zhang Y, et al.
Eur J Pharmacol
. 2015 Jun;
764:228-239.
PMID: 26086859
Tetrandrine (Tet), a bisbenzylisoquinoline alkaloid, has been reported to possess anti-tumour activity. However, its effects on human glioma remain unknown. In this study, we demonstrated that Tet inhibited human glioma...
6.
Liu S, Wang X, Li X, Liang J, Liu L, Lu Y, et al.
Biomed Pharmacother
. 2014 Oct;
68(8):1031-6.
PMID: 25312823
The aim of this study was to investigate the antitumor effect of zoledronic acid (ZOL) in the NB4 human acute promyelocytic leukemia (APL) cell line and explore the potential mechanism...
7.
Zhang Y, Wang S, Ma J, Li H, Ye J, Xie S, et al.
J Neurooncol
. 2014 Sep;
121(1):41-52.
PMID: 25173233
Combination therapy to inhibit cancer stem cells may have important clinical implications. Here, we examine the molecular mechanisms by which epigallocatechin gallate (EGCG), a bioactive polyphenol in green tea, inhibits...
8.
Zhu H, Xie S, Fang M, Zhang J, Weng Z, Zhong X
Neuropathology
. 2013 Dec;
34(3):227-35.
PMID: 24354477
Drug resistance is one of the most formidable obstacles for treatment of glioma. Eukaryotic initiation factor 4E-binding protein (4E-BP1), a key component in the rate-limiting step of protein translation initiation,...
9.
Yan Y, Xie Q, Li F, Zhang Y, Ma J, Xie S, et al.
Neuropathology
. 2013 Oct;
34(2):128-34.
PMID: 24112388
Chemotherapy has been considered as an effective treatment for malignant glioma; however, it becomes increasingly ineffective with tumor progression. Epithelial-to-mesenchymal transition (EMT) is a process whereby cells acquire morphologic and...
10.
Liu K, Luo F, Xie S, Tang L, Chen M, Wu X, et al.
Chin J Cancer Res
. 2013 Jan;
24(2):116-23.
PMID: 23359767
Objective: To explore the effects and mechanism of glycogen synthase kinase 3β (GSK-3β) inhibitor (2'Z,3'E)-6-bromo-indirubin-3'-oxime (BIO) on drug resistance in colon cancer cells. Methods: The colon cancer SW480 and SW620...